About OCV Partners
OCV Partners is a venture capital firm founded in 2016. It is primarily based out of Los Angeles, United States. As of Jan 2025, OCV Partners has invested in 20 companies. It primarily invests in Series C round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and High Tech. Most recently it participated in the $***** Series C round of Rad AI Overall, OCV Partners portfolio has seen 1 unicorn, 3 IPOs and 1 acquisition including key companies like TechStyle, Praxis Medicines and Precision BioSciences. A lot of funds co-invest with OCV Partners, with names like Adage Capital Management sharing a substantial percentage of its portfolio. OCV Partners has team of 5 people including 5 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series C & 1 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
OCV Partners' List of Top Investments
OCV Partners has a portfolio of 20 companies, one of which is a Unicorn. Their most notable investments are in Ockam and Orca AI.Their portfolio spans across United States, Israel and United Kingdom. They have invested in Life Sciences, Enterprise Applications, High Tech and 10 other sectors, across stages such as Series A, Series C and 1 more. Here is the list of top investments by OCV Partners:1. TechStyle
Provider of membership commerce solutions for fashion businesses. Offerings include proprietary software for e-commerce and subscription billing-management tools, personalization solutions, and data-driven services such as designing, merchandising, supply chain management and fulfillment for fashion brands and retailers.
Key facts about TechStyle
- Founded Year: 2010
- Location: El Segundo (United States)
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $340M
- Employee Count: 2,079 as on Apr 27, 2025
- Investors: Western Technology Investment, Spur Capital and 26 Others
- Latest Funding Round: Series C, Aug 28, 2014, $*****
- Highlight: Editors' Pick
Developer of therapies to treat brain disorders. The company has developed Prax-114 to treat mood disorders, Prax-994 to treat movement disorders such as epilepsy, Prax-222 to treat genetic epilepsies, Prax-562 to treat pain disorders, and Prx-120 to treat genetic epilepsies.
Key facts about Praxis Medicines
- Founded Year: 2015
- Location: Boston (United States)
- Annual Revenue: $1M - $10M as on Dec 31, 2024
- Stage: Public
- Total Funding till date: $110M
- Employee Count: 315 as on Aug 31, 2026
- Investors: Point72, Avoro Capital and 11 Others
- Latest Funding Round: Series C, May 04, 2020, $*****
- Highlight: Public
3. Ossio
Ossio focuses on orthopedic fixation using bone regeneration technology. The company has developed OSSIOfiber, a biocomposite material platform that contains reinforcing synthetic bone fibers and bioabsorbable polymer resin. The fiber provides mechanical strength and the resin provides binding property and promotes bone growth.
Key facts about Ossio
- Founded Year: 2014
- Location: Caesarea (Israel)
- Stage: Series C
- Total Funding till date: $89M
- Employee Count: 168 as on Aug 31, 2026
- Investors: MVM, Arc Ventures and 7 Others
- Latest Funding Round: Conventional Debt, Feb 12, 2026, $*****
- Highlight: Editors' Pick
4. Orca AI
Developer of maritime artificial intelligence platform for enhanced situational awareness. The platform offers tools for bridge and office teams to improve safety. It provides situational awareness and autonomous shipping solutions. The company serves commercial shipping and defense and government sectors.
Key facts about Orca AI
- Founded Year: 2018
- Location: Tel Aviv (Israel)
- Stage: Series B
- Total Funding till date: $111M
- Employee Count: 170 as on Aug 31, 2026
- Investors: Brighton Park Capital, Lloyd’s and 11 Others
- Latest Funding Round: Series B, May 06, 2025, $*****
- Highlight: Editors' Pick
5. Rad AI
Developer of radiology artificial intelligence software for workflow and reporting. The software aims to improve efficiency and reduce fatigue for radiologists. It offers tools for report generation, follow-up management, and impression automation. The software integrates into existing workflows with the goal of improving patient care.
Key facts about Rad AI
- Founded Year: 2018
- Location: San Francisco (United States)
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $153M
- Employee Count: 254 as on Aug 31, 2026
- Investors: World Innovation Lab, Kickstart Fund and 29 Others
- Latest Funding Round: Series C, Jan 03, 2025, $*****
- Highlight: Editors' Pick
OCV Partners' Year-on-Year Investment Trends
OCV Partners has invested in 20 companies over the last 8 years, with an average of 1 new investment annually in the last 5 years. In 2025, it made 1 investment. Its most recent first time investment was in TORL BioTherapeutics and most recent follow-on round was in Rad AI.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 1 | 1 |
2024 | 0 | 4 | 4 |
2023 | 1 | 0 | 1 |
2022 | 1 | 0 | 1 |
2021 | 3 | 2 | 5 |
2020 | 3 | 1 | 4 |
2019 | 4 | 0 | 4 |
2018 | 2 | 0 | 2 |
OCV Partners' Investments by Stage
OCV Partners has made 8 investments in Series A stage with an average round size of $34.4M, 4 investments in Series C stage with an average round size of $48.1M and 2 investments in Series B stage with an average round size of $134M.Stage of entry | No. of Investments |
|---|---|
Series A | 8 |
Series C | 4 |
Series B | 2 |
Note: We have considered here, only first round of investments
OCV Partners' Investments by Sector
OCV Partners has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, High Tech, Artificial Intelligence - Industry Applications and Enterprise Infrastructure. Notably, it has invested in 17 Enterprise (B2B) companies, 16 Tech companies, 8 Software companies and at least 3 companies focusing on AI-Native.Sector | No. of Investments |
|---|---|
Life Sciences | 7 |
Enterprise Applications | 6 |
High Tech | 4 |
Artificial Intelligence - Industry Applications | 3 |
Enterprise Infrastructure | 2 |
Others | 11 |
Note: We have considered here, only first round of investments
OCV Partners' Investments by Geography
OCV Partners has made most investments in United States (11), followed by Israel where it has made 3 investments.Country | No. of Investments |
|---|---|
United States | 11 |
Israel | 3 |
United Kingdom | 1 |
Note: We have considered here, only first round of investments
OCV Partners' recent investments
OCV Partners has not made any investment in 2026 so far.Here are the most recent investments by OCV Partners:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jan 03, 2025 | United States | Series C | 4126 | ||
Dec 02, 2024 | Israel | Series C | 7981 | [+3] | |
May 23, 2024 | Israel | Series B | 3262 | [+3] | |
Mar 28, 2024 | United States | Series C | 6363 | [+6] | |
Mar 08, 2024 | United States | Series B | 7186 | [+4] |
Unicorns in OCV Partners' Portfolio
OCV Partners has 1 unicorn in its portfolio - TechStyle. The most recent unicorn in their portfolio is TechStyle which became a unicorn in 2014, 12 years before OCV Partners first invested in it.Here is a list of unicorns in OCV Partners' portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
70 | Provider of membership commerce solutions for fashion businesses | 2010 | El Segundo | Series C | ruvisny |
IPOs and Publicly Listed companies in OCV Partners' Portfolio
3 of OCV Partners' portfolio companies have become public. Finch Therapeutics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Mar 2021 at marketcap of $801M and Praxis Medicines got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $698M.Here are OCV Partners' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 19, 2021 | Jul 19, 2019 | Series C | 4426 | |
Oct 16, 2020 | May 04, 2020 | Series C | 5488 | |
Mar 28, 2019 | Jun 08, 2018 | Series B | 4699 |
Acquired companies in OCV Partners' Portfolio
1 company from OCV Partners' portfolio has been acquired. The most recent acquisition was Invoice2go in Jul 2021 by Bill for $*****.Here are OCV Partners' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 19, 2021 | Sep 11, 2018 | Series C | 2534 |
Team profile of OCV Partners
OCV Partners has a team of 5 members including 5 Partners located in United States. OCV Partners' team does not sit on the board of any company as of now.Here is a list of all team members in OCV Partners:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Los Angeles | - | ||
Partner | Los Angeles | - | ||
Partner | Los Angeles | - | ||
Partner | - | - | ||
Partner | San Francisco | - |
Co-investors of OCV Partners
Over the past 8 years, 129 investors have co-invested in OCV Partners's portfolio companies. This includes funds and angels.
- Invested before OCV Partners: MizMaa, Ray Car Carriers and 41 others have invested in rounds before OCV Partners. There is 1 company where MizMaa has invested before OCV Partners and 1 company where Ray Car Carriers has invested before OCV Partners.
- Top Co-investors of OCV Partners: 52 investors entered a company along with OCV Partners. These include investors like Adage Capital Management (2 companies).
- Invested after OCV Partners: A total of 34 investors have invested in OCV Partners's portfolio after their investments. Top Investors include MVM (1 company), Questa Capital (1 company) and Courage Capital Management (1 company).
Recent News related to OCV Partners
•
4 Health Systems Join Rad AI Investment RoundHealthcare Innovation•May 21, 2025•Rad AI, Advocate Health, Transformation Capital, Memorial Hermann and 8 others
•
Rad Ai Closes $60m Series C To Further Solidify Leadership In Healthcare Generative Aiintelligence360•Feb 07, 2025•Rad AI, Transformation Capital, Khosla Ventures, World Innovation Lab and 4 others
•
Rad AI Closes $60Million Series C to Further Solidify Leadership in Healthcare Generative AIAiThority•Jan 30, 2025•Rad AI, Transformation Capital, Khosla Ventures, World Innovation Lab and 4 others
•
AI radiology startup raises $60 million in Series C roundThe Business Journals•Jan 29, 2025•Rad AI, Transformation Capital, Khosla Ventures, World Innovation Lab and 6 others
•
OSSIO Raises $27.6 Million to Accelerate Its Commercial Engine as High Demand for Bio-Integrative Fixation Technology Continuesintelligence360•Dec 20, 2024•Ossio, Questa Capital, MVM, OCV Partners and 1 other
•
OSSIO Raises $27.6 Million to Accelerate Its Commercial Engine as High Demand for Bio-Integrative Fixation Technology ContinuesBusiness Wire•Dec 02, 2024•Ossio, Questa Capital, MVM, Courage Capital Management and 2 others
•
Insurtech Orca AI received $23 million to develop naval securityforinsurer.com•Jun 18, 2024•Orca AI, OCV Partners, MizMaa, Santa Barbara Venture Partners and 1 other
•
Orca ai raises $ 23 millionCoverager•May 28, 2024•Orca AI, OCV Partners, MizMaa, Ankona Capital and 1 other
•
ORCA AI, which develops automatic navigation vessels using AI, implements $ 23 million in the series B -roundStartup Log•May 25, 2024•Orca AI, NorthStandard, OCV Partners, MizMaa and 3 others
•
Autonomous shipping startup Orca AI tops up with $23M led by OCV Partners and MizMaa VenturesTechCrunch+•May 23, 2024•Orca AI, OCV Partners, MizMaa, Ankona Capital and 2 others
